Better Therapeutics, Inc.
BTTXDrugs in Pipeline
1
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Beclometasone Dipropionate and Formoterol Inhalation Aerosol | Phase 3 | Asthma (Diagnosis) | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Better Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Better Therapeutics, Inc.'s (BTTX) pipeline across Phase 3. Its lead program is Beclometasone Dipropionate and Formoterol Inhalation Aerosol (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Better Therapeutics, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Better Therapeutics, Inc. (BTTX) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track BTTX biotech catalysts?→
Add BTTX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Better Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.